<DOC>
<DOCNO>
EP-0010398
</DOCNO>
<TEXT>
<DATE>
19800430
</DATE>
<IPC-CLASSIFICATIONS>
C07D-209/60 A61P-37/00 <main>C07D-209/38</main> A61K-31/403 C07D-295/00 A61P-37/08 A61K-31/495 A61K-31/405 A61P-11/00 C07D-209/38 C07D-295/067 C07D-209/00 C07D-403/06 A61K-31/404 C07D-209/40 A61K-31/535 
</IPC-CLASSIFICATIONS>
<TITLE>
isatin derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same.
</TITLE>
<APPLICANT>
fujisawa pharmaceutical cojp<sep>fujisawa pharmaceutical co. ltd.<sep>fujisawa pharmaceutical co., ltd.3, doshomachi 4-chome higashi-kuosaka-shi osaka 541jp<sep>fujisawa pharmaceutical co., ltd. <sep>
</APPLICANT>
<INVENTOR>
namiki takayuki<sep>oku teruo<sep>teraji tsutomu<sep>namiki, takayuki<sep>oku, teruo<sep>teraji, tsutomu<sep>namiki, takayukino. 2-2-10, midorigaokaikedajp<sep>oku, teruono. 2-2-23-406, wakayamadaishimamoto-cho mishima-gun, osaka-fujp<sep>teraji, tsutomuno. 6-20-6, kofudaitoyono-cho toyono-gun, osaka-fujp<sep>namiki, takayuki <sep>oku, teruo<sep>teraji, tsutomu<sep>namiki, takayukino. 2-2-10, midorigaokaikedajp<sep>oku, teruono. 2-2-23-406, wakayamadaishimamoto-cho mishima-gun, osaka-fujp<sep>teraji, tsutomuno. 6-20-6, kofudaitoyono-cho toyono-gun, osaka-fujp<sep>
</INVENTOR>
<ABSTRACT>
the isatin derivatives are compounds having the  formula:-    wherein r¹ and r² are each hydrogen, halogen, lower alkyl,  lower alkoxy, halo(lower)-alkyl, acylamino or  heterocyclic group containing at least one imino  group, or   r¹ and r² are combined together to form a benzene  ring,   r³ is oxo or a group of the formula: = n-or⁵, in  which r⁵ is hydrogen or lower alkyl,   r⁴ is hydrogen; ar(lower)alkyl optionally having  halogen, carboxy or esterified carboxy; aryl  optionally having halogen; acyl; or 10, 11-­ dihydro-5h-dibenzo[a, d]- cycloheptenyl,   a is lower alkylene optionally having hydroxy and   y is (c₁ to c₃) alkylene,   and their pharmaceutically acceptable salts.  the compounds  are prepared by the reaction of isatin or its substituted deriva­ tives with suitable substituent group-containing compounds.  pharmaceutical compositions containing the isatin  derivatives of their pharmaceutically acceptable salts are use­ ful for treating allergic symptoms.  
</ABSTRACT>
</TEXT>
</DOC>
